华大九天：关于持股5%以上股东减持股份预披露公告

Core Viewpoint - BGI Genomics announced a plan for significant share reduction by major shareholders, indicating potential shifts in ownership structure and investor sentiment [1] Group 1: Shareholder Actions - The National Integrated Circuit Industry Investment Fund Co., Ltd. and Shanghai Jianyuan Equity Investment Fund Partnership plan to reduce their holdings by a total of 19,635,753 shares [1] - This reduction represents 3.6% of the total share capital of BGI Genomics [1] - The share reduction will occur between February 2 and May 1, 2026, through centralized bidding and block trading methods [1]